Simplex Trading’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,601
| Closed | -$668K | – | 9230 |
|
|
2025
Q4 | $718K | Buy |
+3,601
| New | +$653K | ﹤0.01% | 2949 |
|
|
2025
Q2 | – | Sell |
-394
| Closed | -$52.5K | – | 8790 |
|
|
2025
Q1 | $59K | Sell |
394
-1,625
| -80% | -$272K | ﹤0.01% | 5601 |
|
|
2024
Q4 | $372K | Sell |
2,019
-1,150
| -36% | -$222K | ﹤0.01% | 3842 |
|
|
2024
Q3 | $624K | Buy |
+3,169
| New | +$659K | ﹤0.01% | 3354 |
|
|
2024
Q2 | – | Sell |
-2,970
| Closed | -$673K | – | 8924 |
|
|
2024
Q1 | $804K | Buy |
2,970
+808
| +37% | +$193K | ﹤0.01% | 3353 |
|
|
2023
Q4 | $511K | Buy |
+2,162
| New | +$425K | ﹤0.01% | 3676 |
|
|
2023
Q3 | – | Sell |
-2,487
| Closed | -$511K | – | 8807 |
|
|
2023
Q2 | $522K | Buy |
+2,487
| New | +$495K | ﹤0.01% | 3272 |
|
|
2023
Q1 | – | Sell |
-1,035
| Closed | -$235K | – | 9166 |
|
|
2022
Q4 | $225K | Buy |
1,035
+139
| +16% | +$30.4K | ﹤0.01% | 4084 |
|
|
2022
Q3 | $176K | Buy |
+896
| New | +$193K | ﹤0.01% | 4776 |
|
|
2022
Q1 | – | Sell |
-6,740
| Closed | -$2.08M | – | 10517 |
|
|
2021
Q4 | $2.54M | Buy |
+6,740
| New | +$2.62M | ﹤0.01% | 1786 |
|
|
2021
Q2 | – | Sell |
-1,160
| Closed | -$387K | – | 10115 |
|
|
2021
Q1 | $336K | Buy |
+1,160
| New | +$322K | ﹤0.01% | 3996 |
|
|
2020
Q1 | – | Sell |
-2,721
| Closed | -$408K | – | 7676 |
|
|
2019
Q4 | $415K | Buy |
2,721
+1,210
| +80% | +$168K | ﹤0.01% | 2936 |
|
|
2019
Q3 | $200K | Buy |
+1,511
| New | +$203K | ﹤0.01% | 3562 |
|
|
2018
Q4 | – | Sell |
-200
| Closed | -$25K | – | 7101 |
|
|
2018
Q3 | $26K | Buy |
+200
| New | +$24.7K | ﹤0.01% | 5742 |
|
|
2018
Q2 | – | Sell |
-12,178
| Closed | -$1.32M | – | 7422 |
|
|
2018
Q1 | $1.3M | Buy |
12,178
+7,028
| +136% | +$758K | 0.06% | 300 |
|
|
2017
Q4 | $563K | Buy |
5,150
+4,322
| +522% | +$470K | 0.02% | 656 |
|
|
2017
Q3 | $89K | Sell |
828
-1,578
| -66% | -$162K | ﹤0.01% | 1813 |
|
|
2017
Q2 | $243K | Buy |
2,406
+2,370
| +6,583% | +$218K | 0.01% | 1077 |
|
|
2017
Q1 | $3K | Buy |
+36
| New | +$3.06K | ﹤0.01% | 4953 |
|
|
2016
Q4 | – | Sell |
-35
| Closed | -$2.66K | – | 5911 |
|
|
2016
Q3 | $2K | Buy |
+35
| New | +$2.93K | ﹤0.01% | 4913 |
|
|
2015
Q1 | – | Sell |
-79
| Closed | -$5.83K | – | 5021 |
|
|
2014
Q4 | $5K | Buy |
+79
| New | +$4.95K | ﹤0.01% | 3064 |
|
Other funds holding CRL
VCM
VPM
Simplex Trading's CRL Position: Q1 2026 in Review
Simplex Trading sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 3,601 shares — an estimated $668K sold.
Simplex Trading first reported a position in CRL in Q4 2014 and held it in 21 quarters. The position peaked at $2.54M in Q4 2021. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Simplex Trading reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 3,601 Charles River Laboratories shares in Q1 2026, an estimated $668K.
- Simplex Trading first reported a position in Charles River Laboratories in Q4 2014 and held it in 21 quarters.
- Simplex Trading's Charles River Laboratories position peaked at $2.54M in Q4 2021.
- 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.